These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38307238)

  • 1. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
    Xian Y; Wang X; Yu Y; Chen X
    Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating
    Zhang ZZ; Qin XH; Zhang J
    Am J Physiol Endocrinol Metab; 2019 Jun; 316(6):E1050-E1060. PubMed ID: 30835506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
    Liu X; Li J; Li X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway.
    He Y; Dan Y; Gao X; Huang L; Lv H; Chen J
    Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E598-E608. PubMed ID: 33284093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
    Chen J; Sun Y; Chen L; Zhou Y
    Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
    Liu L; Gao Y; Yao S
    Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):45. PubMed ID: 38289614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JQ1 inhibits high glucose-induced migration of retinal microglial cells by regulating the PI3K/AKT signaling pathway.
    Zhu Y; Guo L; Zou J; Wang L; Dong H; Yu S; Zhang L; Li J; Qu X
    Math Biosci Eng; 2022 Sep; 19(12):13079-13092. PubMed ID: 36654036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.
    Cao YL; Liu DJ; Zhang HG
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4427-4430. PubMed ID: 30058674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qi-Ju-Di-Huang-Pill delays the progression of diabetic retinopathy.
    Zhao C; Ma G; Tao S; Wang M; Chen Z; Fang Y; Shi W
    J Ethnopharmacol; 2024 Apr; 323():117751. PubMed ID: 38216102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connexin 43 (Cx43) regulates high-glucose-induced retinal endothelial cell angiogenesis and retinal neovascularization.
    Shi W; Meng Z; Luo J
    Front Endocrinol (Lausanne); 2022; 13():909207. PubMed ID: 36120455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFL7 affects the migration of epidermal stem cells in refractory diabetic wounds by regulating Notch signaling pathway.
    Chang J; Sun Y; Meng X; Zeng F; Wang X
    Regen Med; 2023 Feb; 18(2):137-153. PubMed ID: 36530156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
    Wang XL; Xian Y; Chen XL
    Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
    Han N; Tian W; Yu N; Yu L
    J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharides from Ostrea rivularis alleviate type II diabetes induced-retinopathy and VGEF
    Chen Y; Dong J; Liu W; Xia Q; Liu T; Liu S; Song Z; Li S
    Int J Biol Macromol; 2024 Nov; 279(Pt 4):135547. PubMed ID: 39265902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin-Interacting Protein Inhibited Vascular Endothelial Cell-Induced HREC Angiogenesis Treatment of Diabetic Retinopathy.
    Yan J; Deng J; Cheng F; Zhang T; Deng Y; Cai Y; Cong W
    Appl Biochem Biotechnol; 2023 Feb; 195(2):1268-1283. PubMed ID: 36346561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine mitigates high glucose-induced retinal endothelial dysfunction by inhibiting PI3K/Akt/mTOR pathway-mediated autophagy.
    Yang Q; Li S; Zhou Z; Yang X; Liu Y; Hao K; Fu M
    Bioengineered; 2022 Mar; 13(3):7515-7527. PubMed ID: 35259050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.